Russia's military has started a mass coronavirus vaccination campaign which aims to innoculate more than 400,000 servicemen, Defence Minister Sergei Shoigu announced on Friday.

Shoigu said that over 2,500 soldiers had already been vaccinated, adding that by the end of the year the number is expected to reach 80,000.

Russia this week said that its Sputnik V coronavirus vaccine was 95 percent effective according to preliminary data -- similar to other international vaccine makers that have also published test results showing efficacy rates of 90 percent and higher.

Sputnik V's developers have touted it as easier to store than some alternatives and at less than $10 (8.38 euros) per dose the cheapest among frontrunners in a global race to develop a vaccine.

The Sputnik V vaccine -- dubbed after the Soviet-era satellite -- was registered in August and is currently undergoing its third and final stage of trials involving more than 40,000 volunteers.

Shoigu on Friday said that more than 400,000 servicemen of Russia's armed forces will be vaccinated against Covid-19 following an order from President Vladimir Putin.

The minister did not specify whether vaccination will be voluntary for soldiers, many of whom are drafted into the army for compulsory service.

He added that some 500 vaccinated servicemen with high levels of antibodies are involved in research of plasma treatment which has proven "effective in severe cases of the infection".

Russia's defence ministry was involved in the initial stages of developing Sputnik V and its servicemen were among the first volunteers to receive the jab during early stage trials.

Shoigu, 65, was himself among a number of top Russian officials who received the vaccine earlier this year.

More than 4,100 servicemen have tested positive for coronavirus since the start of the pandemic in the spring, the defence ministry said on Wednesday.

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Pakistanis join final trials for China-made vaccine
Islamabad (AFP) Nov 26, 2020
Thousands of volunteers are flocking to research hospitals across Pakistan to join final-stage clinical trials of a Chinese-made vaccine for the coronavirus. It is the first time Pakistan has participated in such a trial, which comes amid a string of positive vaccine announcements by Western pharmaceutical companies this month. The vaccine is being developed by CanSinoBio and the Beijing Institute of Biotechnology China. "I have volunteered myself for a noble cause that will help humanity," ... read more